Spectroscopic identification of an amorphous-to-crystalline drug transition in a solid dispersion SCH 48461 capsule formulation
- 1 December 1997
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 16 (4) , 661-673
- https://doi.org/10.1016/s0731-7085(97)00083-6
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Asymmetric synthesis and absolute stereochemistry of cholesterol absorption inhibitor, SCH 48461Tetrahedron Letters, 1994
- 2-Azetidinones as Inhibitors of Cholesterol AbsorptionJournal of Medicinal Chemistry, 1994
- Solid-state NMR and IR for the analysis of pharmaceutical solids: Polymorphs of fosinopril sodiumJournal of Pharmaceutical and Biomedical Analysis, 1993
- The applicability of powder X-ray diffraction to the quantification of drug substance polymorphs using a model organic systemPowder Diffraction, 1993
- Thermal analytical and infrared spectroscopic investigations on polymorphic organic compounds?VIIMicrochimica Acta, 1990
- A comparative spectroscopic investigation of three pseudopolymorphs of testosterone using solid-state i.r. and high-resolution solid-state NMRSpectrochimica Acta Part A: Molecular Spectroscopy, 1987
- The filling of molten and thixotropic formulations into hard gelatin capsulesJournal of Pharmacy and Pharmacology, 1980
- Pharmaceutical Applications of Solid Dispersion Systems: X-Ray Diffraction and Aqueous Solubility Studies on Griseofulvin-Polyethylene Glycol 6000 SystemsJournal of Pharmaceutical Sciences, 1977
- Characterization of Habits and Crystalline Modification of Solids and Their Pharmaceutical ApplicationsJournal of Pharmaceutical Sciences, 1975
- Pharmaceutical Applications of Solid Dispersion SystemsJournal of Pharmaceutical Sciences, 1971